![Michelle Carpenter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michelle Carpenter
Nessuna posizione attualmente
Storia della carriera di Michelle Carpenter
Precedenti posizioni note di Michelle Carpenter
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACUCELA INC | Direttore Tecnico/Scientifico/R&S | 11/08/2011 | 25/03/2013 |
Consigliere Generale | 11/08/2011 | - | |
SONOMA PHARMACEUTICALS, INC. | Consigliere Generale | - | - |
Oclassen Pharmaceuticals, Inc.
![]() Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Corporate Officer/Principal | - | - |
INSITE VISION INC. | Corporate Officer/Principal | - | - |
Santen, Inc.
![]() Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Consigliere Generale | 06/05/2011 | - |
Corporate Officer/Principal | - | 06/05/2011 | |
Mylan Specialty LP
![]() Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Responsabile della Conformità | 06/05/2011 | - |
Consigliere Generale | 01/04/2002 | 06/05/2011 |
Formazione di Michelle Carpenter
Golden Gate University | Graduate Degree |
University of California, Santa Barbara | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
General Counsel | 4 |
Corporate Officer/Principal | 3 |
Compliance Officer | 1 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SONOMA PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Mylan Specialty LP
![]() Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Health Technology |
Santen, Inc.
![]() Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
InSite Vision, Inc.
![]() InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology InSite Vision Inc. develops and markets ophthalmic pharmaceutical products that designs to treat a range of common eye problems, including ocular infection, pain and inflammation in ocular surgery, and glaucoma. Its products include AzaSite, Besivance, AzaSite Plus, DexaSite, AzaSite Xtra, and ISV-10 and 303. The company was founded by Merwin Jerry Hansen in 1986 and is headquartered in Alameda, CA. | Health Technology |
Oclassen Pharmaceuticals, Inc.
![]() Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Health Technology |
Acucela, Inc.
![]() Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Michelle Carpenter
- Esperienza